BAYER AGREES to BUY CONCEPTUS for $ 1.1 billion

The German chemicals and pharmaceutical Bayer announced that it will buy California-based Conceptus to boost its segment of contraceptives. The agreement says the American company at $ 1.1 billion.
Bayer will launch a tender offer of $ 31 per share in cash by Conceptus in the next ten days. The transaction should be completed in the middle of this year, depending on regulatory approval.
The announcement comes after a survey in Bayer's birth control products. The German company faces a series of processes in the us who claim that it does not adequately informed women about the risk of thrombosis and other side effects of Yaz and Yasminelle, Yasmin contraceptive.
Bayer acquires manufacturer of Schiff vitamins
Separately, the Conceptus reported that had profit of $ 1.86 million in the first quarter of this year, with increased sales to $ 34.1 million. With about 300 employees, the Conceptus recorded annual sales of about $ 141 million in 2012. The information is from Dow Jones.